LILLY VENTURES
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under management and focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.
LILLY VENTURES
Social Links:
Industry:
Financial Services Impact Investing Innovation Management Life Science Venture Capital
Founded:
2001-01-01
Status:
Active
Contact:
(317) 429-0140
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Mimecast Amazon Ohio Region
Similar Organizations
AltsAxis
AltsAxis is a data-driven mobile platform that provides a vast universe of alternative asset managers and social networks.
Koch Disruptive Technologies
Koch Disruptive Technologies is a venture capital firm that invests in technologies to improve businesses and create new opportunities.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-05 | IpiNovyx Bio | Lilly Ventures investment in Seed Round - IpiNovyx Bio | 10 M USD |
| 2020-06-09 | Evox Therapeutics | Lilly Ventures investment in Convertible Note - Evox Therapeutics | 10 M USD |
| 2018-11-13 | Kymera Therapeutics | Lilly Ventures investment in Series B - Kymera Therapeutics | 65 M USD |
| 2018-07-26 | Sutro Biopharma | Lilly Ventures investment in Series E - Sutro Biopharma | 85.4 M USD |
| 2018-06-05 | Nimbus Therapeutics | Lilly Ventures investment in Series C - Nimbus Therapeutics | 65 M USD |
| 2017-10-30 | Kymera Therapeutics | Lilly Ventures investment in Series A - Kymera Therapeutics | 30 M USD |
| 2017-01-06 | Cavion | Lilly Ventures investment in Series A - Cavion | 26.1 M USD |
| 2015-12-01 | Symic Biomedical | Lilly Ventures investment in Series A - Symic Biomedical | 25 M USD |
| 2015-07-16 | Protagonist Therapeutics | Lilly Ventures investment in Series C - Protagonist Therapeutics | 40 M USD |
| 2015-03-23 | Aeglea BioTherapeutics | Lilly Ventures investment in Series B - Aeglea BioTherapeutics | 44 M USD |
Newest Events participated
Participated in Grace Hopper Celebration of Women in Computing 2017
on 2017-10-04 as sponsor
Participated in Biotech and Money London
on 2017-02-07 as sponsor
More informations about "Lilly Ventures" on Search Engine
Lilly Ventures - Investments, Portfolio & Company Exits
27. exits. Lilly Ventures's most notable exits include Kymera Therapeutics , Sutro Biopharma , and Coherus Biosciences. Unlock for free. Investments. Number of …See details»
Corporate Venturing - Harvard Business Review
By 2013, Lilly Ventures had been involved in more than 30 such collaborations, many of which gave its parent company valuable insights …See details»
Lilly Ventures — 36 Portfolio companies, 69 Investments, Team …
$27M. Portfolio companies 37. Rounds per year 3.04. Lead investments 13. Follow on index. 0.47. Exits 25. Key employees 2. http://www.lillyventures.com/ Indianapolis, …See details»
Lilly Ventures Investor Profile: Portfolio & Exits
Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Lilly Ventures. Use the PitchBook …See details»
List of top Lilly Ventures Portfolio Companies - Crunchbase
Feb 11, 2005 Lilly Ventures is an Indiana-based venture capital firm that provides investment to companies in the life sciences sector. This list of organizations invested …See details»
Lilly's Social Impact Venture Capital Portfolio Poised to Grow to …
INDIANAPOLIS, May 9, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has allocated an additional $50 million to its now $300 million Social Impact Venture Capital …See details»
Lilly Announces $30 Million Limited Partner Investment in Unseen ...
INDIANAPOLIS, Jan. 15, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $30 million limited partner investment in Unseen Capital Health Fund LP, a …See details»
Lilly Ventures Portfolio Investments, Lilly Ventures Funds, Lilly ...
Dec 15, 2003 Lilly Ventures is the venture capital arm of pharmaceutical company, Eli Lilly. Lilly Ventures will look at early to expansion stage investments. Lilly Ventures …See details»
Lilly's Social Impact Venture Capital Portfolio Poised to Grow to …
INDIANAPOLIS, May 9, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) has allocated an additional $50 million to its now $300 million Social Impact Venture Capital …See details»
SEC Filing | Eli Lilly and Company
As of the date hereof, Lilly Ventures Fund I, LLC (“the Fund”) and Eli Lilly and Company ("Lilly") own beneficially and of record 2,568,543 shares of Common Stock of Aeglea …See details»
Becoming an investor - Medium
Jul 22, 2023 My time in operating roles is now paying off in spades as I lead Lilly Ventures’ first Tech investing strategy and advise senior leaders across the …See details»
Lilly Ventures - Funding, Financials, Valuation & Investors
Lilly Ventures is an Indiana-based venture capital firm that provides investment to companies in the life sciences sector.See details»
Partner with Lilly | Scientific Partnering | Eli Lilly and Company
Let's Grow Together. We have a proven legacy of successfully funding, developing and accelerating innovation to address unmet needs. In fact, collaboration and partnerships …See details»
Emily Troyer - Sr. Associate - Lilly Ventures - LinkedIn
Lilly Ventures | External Innovation. Indianapolis, Indiana, United States. 500 followers 499 connections. View mutual connections with Emily. Welcome back. Eli Lilly and …See details»
Speakers - Scope Summit
John Pavletic leads Lilly Ventures’ Tech investing strategy globally. This strategy focuses on next generation technologies and business models that can advance drug discovery …See details»
A New Use for Wegovy Opens the Door to Medicare Coverage …
3 days ago This means that the FDA’s approval of the new use for Wegovy potentially opens up access to this drug for 1 in 4 people on Medicare with obesity or overweight. …See details»
Lilly's Social Impact Venture Capital Portfolio Poised to Grow to …
May 9, 2023 Eli Lilly and Company (NYSE: LLY) has allocated an additional $50 million to its now $300 million Social Impact Venture Capital Portfolio, reflecting the company's …See details»
Contact Us - Hero's Bridge
Contact Us - Hero's Bridge. For more information please complete and submit this form, or call 540-341-5378. Our mailing address: 98 Alexandria Pike, Suite 41. Warrenton, VA …See details»
HOME | Neatly Ever After
Hi, Libbi here! I am the face behind Neatly Ever After, a professional organizing business based out of the Warrenton, Virginia area. From everyday moments at home to hiking …See details»
Neatly Ever After Professional Organizing | Warrenton VA
Neatly Ever After Professional Organizing, Warrenton, Virginia. 1,460 likes · 36 talking about this. Professional organizer in Warrenton, Virginia, specializing in ...See details»